TickerFacts.

Solventum Corp (SOLV): Cash & Equivalents

Annual figures by period end, from SEC filings.

$878.00M
As of 2025-12-31
$403.00M
As of 2026-06-30
2023-12-31: $194.00M2024-12-31: $762.00M2025-12-31: $878.00M$878.00M
2023-12-31 Cash & Equivalents (USD) 2025-12-31
Period endedCash & EquivalentsChange YoYSource filing
2025-12-31$878.00M+15.2%2026-02-27, Balance as of period end
2024-12-31$762.00M+292.8%2026-02-27, Balance as of period end
2023-12-31$194.00Mn/a2025-02-28, Balance as of period end

Cash & Equivalents at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCash & EquivalentsChange YoY
Solventum Corp (SOLV)2025-12-31$878.00M+15.2%
Baxter International Inc (BAX)2025-12-31$1.97B+11.5%
ResMed Inc (RMD)2026-06-30$1.47B+21.5%
Dexcom Inc (DXCM)2025-12-31$917.70M+51.4%
Boston Scientific Corp (BSX)2025-12-31$1.97B+374.6%
Becton Dickinson & Co (BDX)2025-09-30$641.00M-62.7%
MiniMed Group, Inc. (MMED)2026-04-24$298.00Mn/m
West Pharmaceutical Services Inc (WST)2025-12-31$791.30M+63.3%
Globus Medical Inc (GMED)2025-12-31$526.16M-32.9%

Compare SOLV, BAX, RMD, DXCM side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗